{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:32:49Z","timestamp":1767108769573,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jiac.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T21:09:39Z","timestamp":1538428179000},"page":"311-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antimicrobial activity of solithromycin and levofloxacin against a murine pneumonia mixed-infection model caused by Streptococcus pneumoniae and anaerobic bacteria"],"prefix":"10.1016","volume":"25","author":[{"given":"Hideo","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5732-209X","authenticated-orcid":false,"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-8767","authenticated-orcid":false,"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.09.003_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijantimicag.2010.01.026","article-title":"Antimicrobial characterization of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates","volume":"35","author":"Farrell","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2018.09.003_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/AAC.01123-09","article-title":"Invitro activity of CEM-101 against Streptococcus pneumonia and Streptococcus pyogenes with defined macrolide resistance mechanisms","volume":"54","author":"McGhee","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.003_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.diagmicrobio.2009.10.013","article-title":"CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria","volume":"66","author":"Putnam","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2018.09.003_bib4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11739-014-1120-5","article-title":"Bacteriology of aspiration pneumonia in patients with acute coma","volume":"9","author":"Lauterbach","year":"2014","journal-title":"Inten Emerg Med"},{"key":"10.1016\/j.jiac.2018.09.003_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2169\/internalmedicine.48.1308","article-title":"Effectiveness of meropenem for the treatment of aspiration pneumonia in elderly patients","volume":"48","author":"Tokuyasu","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2018.09.003_bib6","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","article-title":"Detection of erythromycin-resistant determinants by RCP","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"year":"2015","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. CLSI publication M07-A10","author":"Clinical Laboratory Standards Institute","key":"10.1016\/j.jiac.2018.09.003_bib7"},{"key":"10.1016\/j.jiac.2018.09.003_bib8","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/AAC.06427-11","article-title":"Comparative in\u00a0vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model","volume":"56","author":"Tessier","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.003_bib9","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1128\/IAI.70.8.4226-4238.2002","article-title":"Pathogenesis of pneumococcal pneumonia in cyclosphamide-induced leukopenia in mice","volume":"70","author":"Wang","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2018.09.003_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/01621459.1986.10478363","article-title":"Performance of some resistant rules for outlier labeling","volume":"81","author":"HoaglinDC","year":"1986","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jiac.2018.09.003_bib11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/infdis\/jiu603","article-title":"Combination treatment withmeropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia","volume":"211","author":"Louie","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2018.09.003_bib12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1017\/S0950268806006303","article-title":"Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan","volume":"134","author":"Qin","year":"2006","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jiac.2018.09.003_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijantimicag.2017.01.035","article-title":"Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections","volume":"50","author":"Hawser","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2018.09.003_bib14","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1128\/AAC.00766-12","article-title":"Comparison of plasm, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects","volume":"56","author":"Rodvold","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:58:16Z","timestamp":1761159496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18303003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1341321X18303003"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.09.003","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial activity of solithromycin and levofloxacin against a murine pneumonia mixed-infection model caused by Streptococcus pneumoniae and anaerobic bacteria","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}